Precision medicine in brain cancer: the foundations
Rahaba Marima(South African Medical Research Council), Zodwa Dlamini(South African Medical Research Council), Melvin Ambele(South African Medical Research Council), Victoria P. Belancio(Tulane University), Pontsho Moela(University of Pretoria), Ntlotlang Mokgautsi(University of Pretoria), Egnesious Sambo(Steve Biko Hospital), Olalekan Fadebi(Steve Biko Hospital), Thabiso Victor Miya(Precision Research (United States)), Aadilah Omar(University of the Witwatersrand), Vivash Naidoo(University of the Witwatersrand), Ntombikayise Xelwa(Precision Research (United States))
Cited by 0
Related Papers
Mammalian non-LTR retrotransposons: For better or worse, in sickness and in health
|Genome Research|2008|321
Anti-LRP/LR-Specific Antibody IgG1-iS18 Significantly Reduces Adhesion and Invasion of Metastatic Lung, Cervix, Colon and Prostate Cancer Cells
|Journal of Molecular Biology|2012|53
Cancer and HIV: The Molecular Mechanisms of the Deadly Duo
|Cancers|2024|48
Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor
|Expert Opinion on Therapeutic Patents|2010|35
Prion Interaction with the 37-kDa/67-kDa Laminin Receptor on Enterocytes as a Cellular Model for Intestinal Uptake of Prions
|Journal of Molecular Biology|2010|26